骨质疏松症治疗的规划性方法:一项20年纵向研究的启示
该回顾性研究分析了2002至2022年间44,135例患者记录,评估骨质疏松症治疗率在七个3年时间段内的3年和5年趋势。结果显示治疗率随时间下降,骨质疏松门诊治疗率高于基层医疗诊所,与专科门诊总体相似但时间分层分析中更高,性别差异持续存在。
要点
- 20年间骨质疏松症治疗率从73.9%降至56.5%(3年,p=0.003),从72.7%降至47.4%(5年,p<0.0001)。
- 骨质疏松门诊治疗率高于基层医疗诊所(3年:70.2% vs 56.1%,p<0.0001;5年:60.2% vs 48.5%,p<0.0001)。
- 治疗率在不同保险类型和种族间相似,但女性总体治疗率高于男性。
核心结论
- 在二十年期间,骨质疏松团队报告的治疗率显著高于全国平均水平。
- 骨质疏松门诊与专科门诊的总体治疗率相似,但在时间分层分析中骨质疏松门诊报告了更高的治疗率。
- 不同诊疗场所的疾病严重程度和治疗接受度差异可能影响了结局。
- 治疗率在不同保险类型间一致,但性别差异持续存在。
研究设计与样本
- 回顾性研究,分析2002至2022年间44,135例患者记录(中位年龄76岁),评估七个3年时间段内的3年和5年骨质疏松症治疗趋势。
- 按就诊类型(基层医疗医生[PCP] vs 非PCP[专科门诊或骨质疏松门诊])、保险类型、性别和种族比较治疗率。
- 每个时间段内的统计比较使用卡方检验、Fisher精确检验或采用广义估计方程(GEE)的逻辑回归。
主要发现
- 治疗率随时间下降:3年治疗率从73.9%降至56.5%(p=0.003),5年治疗率从72.7%降至47.4%(p<0.0001)。
- 骨质疏松门诊与专科门诊总体治疗率相似(3年:70.2% vs 67.2%,p=0.124;5年:60.2% vs 57.9%,p=0.856),但在时间分层分析中骨质疏松门诊更高。
- 骨质疏松门诊治疗率高于基层医疗诊所(3年:70.2% vs 56.1%,p<0.0001;5年:60.2% vs 48.5%,p<0.0001)。
- 治疗率在不同保险类型和种族间相似;女性总体治疗率高于男性。
关键数值与推荐
- 3年治疗率从73.9%降至56.5%(p=0.003),5年治疗率从72.7%降至47.4%(p<0.0001)。
- 骨质疏松门诊与专科门诊3年治疗率70.2% vs 67.2%(p=0.124),5年治疗率60.2% vs 57.9%(p=0.856)。
- 骨质疏松门诊与基层医疗诊所3年治疗率70.2% vs 56.1%(p<0.0001),5年治疗率60.2% vs 48.5%(p<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 关于种族的结论受限于非白人人群样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The rationale for this research is to analyze the osteoporosis treatment rate over a 20-year period to understand and improve patient care. The main result of the study indicates that patients who were seen in a structured osteoporosis clinic had significantly higher treatment rates compared to the national benchmark. The significance of this model lies in its ability to provide focused osteoporosis care, which can effectively bridge the existing care gap. PURPOSE: Osteoporosis is underserved. We studied the impact of an osteoporosis care program on treatment rates over a 20-year period. METHODS: This retrospective study 2002-2022 analyzed 3- and 5-year osteoporosis treatment trends across seven 3-year time periods. Treatment rates were compared by visit type (Primary Care Physician [PCP] vs. non-PCP [specialty clinic or osteoporosis clinic]), insurance type, gender, and race. Statistical comparisons within each period were made using chi-square, Fisher's exact tests, or logistic regression with generalized estimating equations (GEE). RESULTS: Among 44,135 patient records (median age 76), treatment rates declined over time, 73.9% to 56.5% (3-year, p = 0.003) and 72.7% to 47.4% (5-year, p < 0.0001). Osteoporosis clinic had overall similar treatment rates as specialty clinic (3-year: 70.2% vs. 67.2%, p = 0.124; 5-year: 60.2% vs. 57.9%, p = 0.856) but higher rates in time-stratified analysis. The osteoporosis clinic had higher treatment rates than PCP clinics (3-year: 70.2% vs. 56.1%, p < 0.0001; 5-year: 60.2% vs. 48.5%, p < 0.0001). Treatment rates were similar by insurance type and race. Women had higher overall treatment rates than men. CONCLUSIONS: Over two decades, our osteoporosis team reported significantly higher treatment rates than national averages. Overall treatment rates were similar between patients seen in osteoporosis and specialty clinic; however, the osteoporosis clinic reported higher rates than the specialty or PCP clinic in time-stratified analysis and PCP clinic overall. Differences in disease severity and treatment receptivity across care settings may have influenced outcomes. Treatment rates were consistent across insurance types,but gender disparities persisted. Conclusions about race were limited by the small non-white population.
引用
- Chang L, Chukwu N, Olenginski T, et al. A programmatic approach to osteoporosis treatment: insight from a 20-year longitudinal study. Osteoporos Int. 2025. PMID: 41428084. doi:10.1007/s00198-025-07811-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。